Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
3(60.0%)
Phase 2
2(40.0%)
5Total
Phase 1(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05129137Phase 1Completed

Pharmacokinetic Study of a Fixed Dose Combination Nefopam Hydrochloride (30 mg) / Paracetamol (500 mg)

Role: collaborator

NCT05808725Phase 1Completed

Amlodipine Freeze-Dried Powder for Oral Solution 5 mg

Role: collaborator

NCT02940561Phase 1Unknown

BE Study in Patients - Methotrexate Tablets

Role: collaborator

NCT02103322Phase 2Completed

Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions

Role: collaborator

NCT02072954Phase 2Completed

Bioequivalence Fasting Study in Patients

Role: collaborator

All 5 trials loaded